Use of PET-CT for the assessment of treatment results in patients with sarcoidosis

Yakar A., Yakar F., SEZER M., Bayram M., ERDOĞAN E. B., Ozkan D., ...Daha Fazla

WIENER KLINISCHE WOCHENSCHRIFT, cilt.127, sa.7-8, ss.274-282, 2015 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 127 Sayı: 7-8
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1007/s00508-014-0647-9
  • Dergi Adı: WIENER KLINISCHE WOCHENSCHRIFT
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.274-282
  • Anahtar Kelimeler: PET-CT, Sarcoidosis, Methylprednisolone, Indomethacine, Spirometry, POSITRON-EMISSION-TOMOGRAPHY, CONVERTING-ENZYME, GA-67, SCANS, THERAPY
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background and aim Sarcoidosis is a multisystem disease of unknown origin. Determining the involvement and the response to the treatment is important. The aim of this study was to identify the effects of methylprednisolone and indomethacine on metabolic activity and pulmonary function test parameters in patients with sarcoidosis.